- Mubadala Investment is taking a closer look at Bridgepoint Group European dialysis clinic chain Diaverum, with the Abu Dhabi sovereign wealth fund aiming to clinch the deal that could value the business at $2.5 billion. The Abu Dhabi sovereign wealth fund is among the final contenders in the race to acquire the Swedish-based Diaverum.
- Bridgepoint is making a new effort to locate a purchaser for the business after the prior attempt to list or sell it in 2020 was fruitless. It is possible that additional potential buyers might show up, and there is no assurance that the discussions will result in a deal.
Why it matters
Mubadala, manages $284 billion in assets, and has been expanding its investments into health care in order to diversify its portfolio. Last year, the fund collaborated with the buyout firm EQT AB to purchase the Swedish medical freight company Envirotainer AB, with an enterprise value of approximately €2.8 billion ($3 billion).
